Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy (Q85672708)
Jump to navigation
Jump to search
scientific article published on 30 July 2015
- Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy |
scientific article published on 30 July 2015 |
|
Statements
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy (English)
30 July 2015